Clinical trials
Trials in Armenia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
135 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 7 |
| 2011 | 6 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 6 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 8 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 13 |
| 2022 | 15 |
| 2023 | 16 |
| 2024 | 15 |
| 2025 | 14 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 67 |
| Recruiting | 29 |
| Unknown status | 12 |
| Active, not recruiting | 10 |
| Terminated | 9 |
| Withdrawn | 4 |
| Enrolling by invitation | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glaukos Corporation | 17 |
| Sanoculis Ltd | 8 |
| Immune Oncology Research Institute | 6 |
| Gynuity Health Projects | 5 |
| EuroPharma, Inc. | 4 |
| ApcinteX Ltd | 3 |
| Ascendis Pharma Endocrinology Division A/S | 3 |
| Astellas Pharma Europe Ltd. | 3 |
| Berlin-Chemie AG Menarini Group | 3 |
| Ciliatech | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glaucoma, Open-Angle | 22 |
| Glaucoma | 10 |
| Ocular Hypertension | 10 |
| Eye Diseases | 7 |
| Dwarfism, Pituitary | 5 |
| Hypertension | 5 |
| Neoplasms | 5 |
| Endocrine System Diseases | 4 |
| Heart Failure | 4 |
| Angioedema | 3 |
Trials
Showing 26 to 50 of 135. Each trial links to its page on Pharma Observatory.
35 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.